
Stephen Gucker
Examiner (ID: 16716)
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1818, 1649, 1647, 1645, 1646, 1812 |
| Total Applications | 799 |
| Issued Applications | 370 |
| Pending Applications | 114 |
| Abandoned Applications | 315 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8503096
[patent_doc_number] => 20120302504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-29
[patent_title] => 'Method Of Reducing Injury To Mammalian Cells'
[patent_app_type] => utility
[patent_app_number] => 13/286071
[patent_app_country] => US
[patent_app_date] => 2011-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 62
[patent_no_of_words] => 29466
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13286071
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/286071 | Method Of Reducing Injury To Mammalian Cells | Oct 30, 2011 | Abandoned |
Array
(
[id] => 10070695
[patent_doc_number] => 09109037
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-18
[patent_title] => 'Anti-SOD1 antibodies and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/882017
[patent_app_country] => US
[patent_app_date] => 2011-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 84
[patent_figures_cnt] => 84
[patent_no_of_words] => 37151
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13882017
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/882017 | Anti-SOD1 antibodies and uses thereof | Oct 24, 2011 | Issued |
Array
(
[id] => 7817472
[patent_doc_number] => 20120064092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'Novel Target for Regulating Multiple Sclerosis'
[patent_app_type] => utility
[patent_app_number] => 13/274054
[patent_app_country] => US
[patent_app_date] => 2011-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11677
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20120064092.pdf
[firstpage_image] =>[orig_patent_app_number] => 13274054
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/274054 | Novel Target for Regulating Multiple Sclerosis | Oct 13, 2011 | Abandoned |
Array
(
[id] => 8239807
[patent_doc_number] => 20120148540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-14
[patent_title] => 'PROLIFERATED CELL LINES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/267346
[patent_app_country] => US
[patent_app_date] => 2011-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 32641
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13267346
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/267346 | Conditioned medium and proliferated cell lines produced therefrom | Oct 5, 2011 | Issued |
Array
(
[id] => 10089087
[patent_doc_number] => 09125894
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-08
[patent_title] => 'Methods for promoting reinnervation of auditory hair cells'
[patent_app_type] => utility
[patent_app_number] => 13/877356
[patent_app_country] => US
[patent_app_date] => 2011-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12612
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877356
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/877356 | Methods for promoting reinnervation of auditory hair cells | Sep 28, 2011 | Issued |
Array
(
[id] => 7587524
[patent_doc_number] => 20110282034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'PREVENTION AND TREATMENT OF COMPLEMENT-ASSOCIATED EYE CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/189301
[patent_app_country] => US
[patent_app_date] => 2011-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18384
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20110282034.pdf
[firstpage_image] =>[orig_patent_app_number] => 13189301
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/189301 | Prevention and treatment of complement-associated eye conditions | Jul 21, 2011 | Issued |
Array
(
[id] => 8814592
[patent_doc_number] => 20130115637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'Efficiency of Prion Conversion in vitro and Sensitivity of Prion Detection'
[patent_app_type] => utility
[patent_app_number] => 13/808860
[patent_app_country] => US
[patent_app_date] => 2011-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 16634
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808860
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/808860 | Efficiency of Prion Conversion in vitro and Sensitivity of Prion Detection | Jul 7, 2011 | Abandoned |
Array
(
[id] => 7509982
[patent_doc_number] => 20110256146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'NEUROPILIN ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/173890
[patent_app_country] => US
[patent_app_date] => 2011-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 32676
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20110256146.pdf
[firstpage_image] =>[orig_patent_app_number] => 13173890
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/173890 | Neuropilin antagonists | Jun 29, 2011 | Issued |
Array
(
[id] => 7807164
[patent_doc_number] => 20120058117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'NEUROPILIN-1 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/166581
[patent_app_country] => US
[patent_app_date] => 2011-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 24793
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058117.pdf
[firstpage_image] =>[orig_patent_app_number] => 13166581
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/166581 | NEUROPILIN-1 INHIBITORS | Jun 21, 2011 | Abandoned |
Array
(
[id] => 8522674
[patent_doc_number] => 20120322082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-20
[patent_title] => 'BIOMARKER FOR AMYOTROPHIC LATERAL SCLEROSIS AND DIAGNOSTIC KIT AND METHOD USED THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/164190
[patent_app_country] => US
[patent_app_date] => 2011-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4151
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13164190
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/164190 | BIOMARKER FOR AMYOTROPHIC LATERAL SCLEROSIS AND DIAGNOSTIC KIT AND METHOD USED THEREOF | Jun 19, 2011 | Abandoned |
Array
(
[id] => 7662264
[patent_doc_number] => 20110311533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'REGULATION OF PROTEIN LEVEL'
[patent_app_type] => utility
[patent_app_number] => 13/103481
[patent_app_country] => US
[patent_app_date] => 2011-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16179
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20110311533.pdf
[firstpage_image] =>[orig_patent_app_number] => 13103481
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/103481 | REGULATION OF PROTEIN LEVEL | May 8, 2011 | Abandoned |
Array
(
[id] => 7651791
[patent_doc_number] => 20110301060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'HIGH THROUGHPUT ASSAYS FOR TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES (TSE)'
[patent_app_type] => utility
[patent_app_number] => 13/084316
[patent_app_country] => US
[patent_app_date] => 2011-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8652
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0301/20110301060.pdf
[firstpage_image] =>[orig_patent_app_number] => 13084316
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/084316 | High throughput assays for transmissible spongiform encephalopathies (TSE) | Apr 10, 2011 | Issued |
Array
(
[id] => 6190270
[patent_doc_number] => 20110172554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'Patient Entry Recording in an Epilepsy Monitoring System'
[patent_app_type] => utility
[patent_app_number] => 13/070357
[patent_app_country] => US
[patent_app_date] => 2011-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 23479
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20110172554.pdf
[firstpage_image] =>[orig_patent_app_number] => 13070357
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/070357 | Patient Entry Recording in an Epilepsy Monitoring System | Mar 22, 2011 | Abandoned |
Array
(
[id] => 8865534
[patent_doc_number] => 20130149237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'DELIVERY SYSTEM FOR DIAGNOSTIC AND THERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/574584
[patent_app_country] => US
[patent_app_date] => 2011-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 33245
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13574584
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/574584 | DELIVERY SYSTEM FOR DIAGNOSTIC AND THERAPEUTIC AGENTS | Jan 20, 2011 | Abandoned |
Array
(
[id] => 8317332
[patent_doc_number] => 08232107
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-31
[patent_title] => 'Methods for measuring the metabolism of neurally derived biomolecules in vivo'
[patent_app_type] => utility
[patent_app_number] => 13/005233
[patent_app_country] => US
[patent_app_date] => 2011-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 12241
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13005233
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/005233 | Methods for measuring the metabolism of neurally derived biomolecules in vivo | Jan 11, 2011 | Issued |
Array
(
[id] => 9936929
[patent_doc_number] => 08986733
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-24
[patent_title] => 'Materials and methods for nerve repair'
[patent_app_type] => utility
[patent_app_number] => 12/966540
[patent_app_country] => US
[patent_app_date] => 2010-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 43
[patent_no_of_words] => 21373
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12966540
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/966540 | Materials and methods for nerve repair | Dec 12, 2010 | Issued |
Array
(
[id] => 6143148
[patent_doc_number] => 20110129857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'Methods Of Detecting Or Monitoring Activity Of An Inflammatory Condition Or Neurodegenerative Condition'
[patent_app_type] => utility
[patent_app_number] => 12/954505
[patent_app_country] => US
[patent_app_date] => 2010-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12424
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20110129857.pdf
[firstpage_image] =>[orig_patent_app_number] => 12954505
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/954505 | Methods Of Detecting Or Monitoring Activity Of An Inflammatory Condition Or Neurodegenerative Condition | Nov 23, 2010 | Abandoned |
Array
(
[id] => 7807619
[patent_doc_number] => 20120058573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'INNOVATIVE BLOOD PLATELETS BIOMARKER FOR EARLY DIAGNOSIS OF ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/318899
[patent_app_country] => US
[patent_app_date] => 2010-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4873
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058573.pdf
[firstpage_image] =>[orig_patent_app_number] => 13318899
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/318899 | Innovative blood platelets biomarker for early diagnosis of alzheimer's disease | Nov 4, 2010 | Issued |
Array
(
[id] => 6202342
[patent_doc_number] => 20110065128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'Methods for Assessing CDK5 Activation and Function'
[patent_app_type] => utility
[patent_app_number] => 12/897433
[patent_app_country] => US
[patent_app_date] => 2010-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9070
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065128.pdf
[firstpage_image] =>[orig_patent_app_number] => 12897433
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/897433 | Methods for Assessing CDK5 Activation and Function | Oct 3, 2010 | Abandoned |
Array
(
[id] => 6095195
[patent_doc_number] => 20110002885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'METHODS OF USING ISOLATED RECOMBINANT POLYPEPTIDE ANTAGONISTS OF SDF-1'
[patent_app_type] => utility
[patent_app_number] => 12/883142
[patent_app_country] => US
[patent_app_date] => 2010-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16760
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20110002885.pdf
[firstpage_image] =>[orig_patent_app_number] => 12883142
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/883142 | METHODS OF USING ISOLATED RECOMBINANT POLYPEPTIDE ANTAGONISTS OF SDF-1 | Sep 14, 2010 | Abandoned |